EpiCast Report: Schizophrenia - Epidemiology Forecast to 2025
"EpiCast
Report: Schizophrenia - Epidemiology Forecast to 2025"
The Report covers current Market Trends, Worldwide Analysis, Global
Forecast, Review, Share, Size, Growth, Effect.
Description-
Schizophrenia
is a severe mental disorder that affects an individuals behaviors,
thoughts, and emotions; it is extremely heterogeneous, and no two
affected individuals will have the same experience. The disorder is
characterized by the presence of positive and negative symptoms.
Positive symptoms can be defined as behaviors that are not usually
seen in healthy individuals; these symptoms tend to be of a psychotic
nature and include hallucinations and delusions. Negative symptoms,
on the other hand, are described as a reduction in normal behaviors.
People with schizophrenia who exhibit negative symptoms show a lack
of motivation, emotions, or interest (apathy), and may sometimes
refuse to speak (mute). The severity of these symptoms varies with
each affected individual.
GlobalData
epidemiologists forecast that the 12-month diagnosed prevalent cases
of schizophrenia in the 7MM will increase from 3,298,475 cases in
2015 to 3,462,096 cases in 2025 at an Annual Growth Rate (AGR) of
0.50%. The US has the highest number of 12-month diagnosed prevalent
cases of schizophrenia among the individual markets of the 7MM
throughout the forecast period, with 1,738,862 cases in 2015 and
1,897,801 cases in 2025, accounting for over 50% of cases in the 7MM.
GlobalData
epidemiologists utilized comprehensive, country-specific data from
peer-reviewed journal articles to arrive at a meaningful, in-depth
analysis and forecast for the 12-month diagnosed prevalent cases of
schizophrenia. Furthermore, GlobalData conducted PMR for
schizophrenia in all of the 7MM to both overcome shortcomings of the
available literature and better aid market-specific forecasting of
schizophrenia. Throughout the 7MM, schizophrenia cases were segmented
by age and sex, allowing for a comprehensive, detailed forecast of
age- and sex-specific schizophrenia to 2025.
Scope
-
The Schizophrenia EpiCast Report provides an overview of the risk
factors and global trends of schizophrenia in the 7MM (US, France,
Germany, Italy, Spain, UK, and Japan). It includes a 10-year
epidemiological forecast for 12-month diagnosed prevalent cases of
schizophrenia segmented by sex and age in these markets.
-
The schizophrenia epidemiology report is written and developed by
Masters- and PhD-level epidemiologists.
-
The EpiCast Report is in-depth, high quality, transparent and
market-driven, providing expert analysis of disease trends in the
7MM.
Reasons
to buy
The
Schizophrenia EpiCast report will allow you to -
-
Develop business strategies by understanding the trends shaping and
driving the global schizophrenia market.
-
Quantify patient populations in the global schizophrenia market to
improve product design, pricing, and launch plans.
-
Organize sales and marketing efforts by identifying the age groups
and sex that present the best opportunities for schizophrenia
therapeutics in each of the markets covered.
Comments
Post a Comment